Trust commissions benzodiazepine review following patient death A patient died by suicide after being permanently prescribed diazepam without a required medical review while awaiting a re-titration of her clozapine prescription.…
Pharmacies pilot test for prevention of oesophageal cancer A total of 12 pharmacies across the East Midlands and London are offering the EndoSign capsule sponge test to patients with persistent heartburn or acid reflux in order to screen for oesophageal cancer.…
Escalation pathways for complex anticoagulation introduced after patient death A patient died from prosthetic aortic valve thrombosis with sub-therapeutic anticoagulation, after clinicians were unable to keep her international normalised ratio within a therapeutic range.…
Updated hypertension case‑finding service draws calls for impact assessment Changes to the specification for the ‘Community pharmacy hypertension case-finding service’ exclude people who have previously had a blood pressure check via the service in the previous five years.…
Boots launches private gonorrhoea vaccination service The high street chain said that gonorrhoea vaccines, which will cost £220 for the full course of two doses, will be available at 160 of its pharmacies.…
MHRA approves orforglipron weight-loss pill The Medicines and Healthcare products Regulatory Agency said its approval of orforglipron makes the UK the first country in Europe to authorise the medication.…
UK patients being recruited for ribupatide trials Researchers will assess the efficacy of up to 10mg doses of weight-loss drug ribupatide in patients with or without diabetes over around an 18-month period.…
Incretin-based weight-loss drugs should not be deliberately continued in pregnancy, consensus guidelines state The guidelines have been drawn up by a multidisciplinary group of experts following a systematic scoping review.…
Best practice for prescribing drugs with dependence potential An overview of the considerations for prescribing medicines with the risk of dependency, including monitoring, discontinuation and the optimisation of therapeutic outcomes.…
NICE recommends heart drug aficamten with simultaneous MHRA approval The National Institute for Health and Care Excellence said that aficamten is likely to be as effective as mavacamten in treating obstructive hypertrophic cardiomyopathy, with “fewer monitoring scans to find the right dose”.…
